News Archives - Page 2 of 805

FridayAug 14, 2026 9:45 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks

Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, with recruitment completion targeted for the third quarter of 2026 and a PMA process expected to begin by the end of 2027. FDA approved a single-arm protocol using a historical microfracture control data package the company owns, and Regentis reports that the first 40 patients closely match that control group. In Europe, where GelrinC already holds CE Mark approval, surgeon training began in the third quarter of 2026 at Humanitas Research Hospital in Milan, supported by an expanded clinical site network and a newly approved manufacturing…

FridayAug 14, 2026 9:00 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Advances North American Rare Earth Portfolio as 2026 Exploration Program Builds Momentum

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals is advancing four rare earth exploration projects across Canada and the U.S. as governments seek to reduce reliance on foreign supply chains. The company has begun its 2026 field program at the Cameron REE Project in British Columbia, focusing on refining targets identified through earlier geochemical and radiometric work. Atikokan in Ontario has produced district-scale REE anomalies, while the Pinard project is entering a Phase 1 exploration program designed to generate and rank targets. The Ogden Bear Lodge project gives Powermax exposure to a…

ThursdayAug 13, 2026 9:00 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market

A new Japanese patent allowance follows a recent such US patent grant, strengthens protection around the organic solvent-free manufacturing process and ready-to-use liquid formulation behind GelrinC, extending the company's intellectual property footprint into one of the world's largest cartilage-repair markets. The process delivers a 5-fold increase in yield along with simplified production and commercial scalability, the manufacturing economics needed to make an off-the-shelf cartilage product commercially viable at scale. The milestone lands as Regentis advances European commercialization and passes the halfway mark in enrollment for its pivotal U.S. trial. Aging populations are pushing joint disease higher on the orthopedic agenda,…

WednesdayAug 12, 2026 9:45 am

From Tokenization to Production: MindWave Innovations Inc. (NYSE American: APUS) Positions MindChain for the Next Phase of Real-World Assets

Real-world asset activity is moving beyond proof-of-concept deployments, with tokenized funds, Treasuries, private credit and commodities increasingly being used across on-chain financial markets. As institutional participation grows, the next challenge is building secure, scalable and risk-mitigated infrastructure capable of supporting tokenized assets in production. MindWave Innovations is positioning MindChain, an insured Ethereum-compatible Layer 2, to support real-world asset applications alongside insurance, AdTech and ClimateTech through dedicated industry-specific subnetworks. For years, the promise of blockchain in financial markets centered on putting traditional assets on chain. Now, the harder question is emerging: what infrastructure is needed to make those assets useful on…

WednesdayAug 12, 2026 9:00 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Researchers recognize that a large share of long-term disability accumulates independent of relapses altogether, a phenomenon researchers call progression independent of relapse activity. That shift has forced researchers to look at what is actually driving PIRA. A major suspect is chronic active lesions, sometimes called smoldering or mixed active-inactive lesions. Rather than broadly suppressing the immune system, Quantum BioPharma’s Lucid-MS is designed to inhibit myelin degradation, preserve myelin and support functional recovery. Multiple sclerosis is quietly shifting how drugmakers define success. Instead of judging a therapy…

TuesdayAug 11, 2026 10:30 am

The Software Premium: How SPARC AI Is Betting That Code, Not Airframes, Decides the Next Drone War

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. Software can be deployed across thousands of existing aircraft without redesigning the airframe, creating a far larger addressable market than hardware. Registration as an AUKUS authorized user gives SPARC AI a permit-free route into U.S. and U.K. defense supply chains. Overwatch's subscription model allows each new connected drone to expand recurring software revenue without requiring additional manufacturing capacity. For decades, military advantage came from building better aircraft. Today's battlefield increasingly rewards something different: making inexpensive aircraft smarter. As drones become cheaper and more disposable,…

TuesdayAug 11, 2026 9:45 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Leverages US Jurisdiction Advantage as Sovereign Gold Demand Reshapes Market

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. The forces underpinning gold's recent strength are structural rather than momentary, even as the price itself has been volatile. All four of Lahontan’s properties sit within the Walker Lane trend and are located entirely within the United States. “This outstanding drill intercept, which includes some of the highest gold grades drilled to date within the Central Calvada deposit, reinforces the importance of the Calvada resource to the Santa Fe Mine project,” notes company exec. Gold's recent strength has increasingly been driven by structural demand…

TuesdayAug 11, 2026 9:00 am

Earth Science Tech Inc. (ETST) Q1 2027 Financial and Operational Results Reflect Compounding Progress of Expansion Strategy

Earth Science Tech, a growing healthcare holding company, recently reported its Q1 2027 financial results, with key highlights including $9.0 million in revenue, $6.3 million in gross profit, $715,697 in net income, $707,131 in net cash, and $10.4 million in total assets. According to the CEO, the Q1 2027 figures reflect steady, compounding progress and are the result of a foundation built in the 2026 financial year. The company’s strategy of carefully acquiring and scaling cash-flowing assets across healthcare, pharmaceutical, and telemedicine sectors, is driving growth to support uplisting and attract institutional capital. Earth Science Tech (OTC: ETST), a diversified…

MondayAug 10, 2026 9:45 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) is Advancing Gold and Silver Assets in One of the World’s Most Productive Mining Jurisdictions

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold Corp. is a dual-listed Canadian/U.S. mine development and exploration company advancing a portfolio of gold and silver assets across Nevada's Walker Lane, one of the world's premier mining jurisdictions. The company’s flagship Santa Fe Mine historically produced more than 359,000 ounces of gold and 702,000 ounces of silver and is being advanced toward a potential restart, supported by an expanding resource base and existing infrastructure. Led by Founder, CEO and President Kimberly Ann, Lahontan combines experienced leadership with a disciplined development strategy…

MondayAug 10, 2026 9:00 am

Nightfood Holdings Inc. (NGTF) Positions TechForce Robotics as the Intelligence Layer Behind Autonomous Enterprise Workforces

TechForce Robotics recently launched its proprietary Robotic Connective Network to enable autonomous robots and AI systems to coordinate enterprise workflows. The company's Robotics as a Service platform combines intelligent software, autonomous robotics, and recurring revenue opportunities across multiple industries. These developments reinforce TechForce's broader vision of creating connected robotic ecosystems that operate as coordinated autonomous workforces. Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, is advancing enterprise automation beyond standalone robots with the launch of its proprietary Robotic Connective Network, a technology framework designed to allow autonomous robots, AI systems, sensors and enterprise software to communicate, coordinate and execute…

Site Search

Company Search

Category: News